International drugs registration system launched in Pakistan
Shares
ISLAMABAD: (APP) An international 'drugs registration system' was being developed in the country to make it at par with the standard of World Health Organization's (WHO) specific format.
According to an official of Drug Regulatory Authority of Pakistan (DRAP), after achieving this international standard based on Committee on Trade and Development (CTD), Pakistani pharmaceutical companies would be able to get registration of their medicines from concerned authorities of major countries of the world.
READ MORE: Drug registration system of WHO standards being implemented in Pakistan
He added with this achievement of international standard on which the DRAP was working, Pakistani companies would be able to get membership of Pharmaceuticals Inspection Cooperation Scheme (PICS) that would help these companies for easily registration in every country of the globe.
This step would help increasing figure of country's medicines export which at present stands at the volume of Rs 167 million against India's figure of Rs 20 billion and Bangladesh Rs 1.8 billion.
He said that after joining PICS not only country's export would touch the highest figure in export of medicines but local pharmaceutical exporters who were looking to export their products to less explored countries would get opportunities.
READ MORE: Drug Regulatory Authority of Pakistan innovative steps to curb spurious drugs sale
He said that PICS would endorse Pakistani pharma companies as reliable exporters of quality medicine. This would help improving the quality of local companies while country's people would get quality medicines.
He said that federal drug surveillance laboratory would soon start functioning in the country. The laboratory would be international standard while labs would also start working at provincial level, he added.
He added under WHO assessment scheme, DRAP would observe gaps and potentials while its transparency would be checked by WHO. He said these laboratories would be pre-qualified from WHO in order to improve the credibility of these labs.
He said that taking cognizance of exercise of discretion in regard to drug pricing in the past, this government for the first time in the country's history introduced a Drug Pricing Policy where discretion in fixing prices was altogether done away with and a Consumer Price Index based system was introduced.
He said that under 2015 drugs pricing policy, the government has strictly controlled the prices of drugs in regard to hardship cases. Under the policy it was the prerogative of the government to fix the prices of those medicines that fall under hardship regime.
READ MORE: Drugs Prices in Pakistan: Local drug manufacturers make amazing announcement
He said there was a set procedure to increase prices like submission of request (certified data) with the government by pharmaceutical companies to raise prices as fixed at ratio of 4% to 6% and up to 8% in accordance with Consumer Price Index (CPI).
He said that the government would take strict action against elements and companies resorting to illegal price hike, to safeguard the interests of the public.
The action will serve as a determent and discourage those elements involved in illegal price hike of drugs. He added all out effort has been made to ensure that drugs are provided to the masses at affordable prices.
